The media regularly covers the number of cases in the triple epidemic or “tripledemic” of influenza, COVID-19, and respiratory syncytial virus. Precision's Maureen Hennessey and Cynthia Miller argue the media should cover more expansive topics beyond the number of cases, and explain why advocacy groups are needed to assist patients dealing with COVID-19, long COVID, and the aftermath.
The “Triple Epidemic” seems to have peaked, but what is it, and what should every industry, health system, and other companies do to mitigate the damage the triple epidemic continues to cause? What should these institutions do to prevent another one? Did vaccine misinformation lead to the current triple epidemic? Did nurse burnout?Infection Control Today® (ICT®) spoke with Precision's Maureen Hennessey and Cynthia Miller for answers to these questions. Installment 1 of 3.
October 2022 heralded another crisis for hospitals and physicians: the tripledemic. It likely won't be the last season for a potential infectious disease calamity, so every healthcare stakeholder must play a role in mitigating the damage. However, issues such as staffing, vaccine fatigue, misinformation, and operational challenges may inhibit successful interventions. Precision's Maureen Hennessey and Cynthia Miller argue for the need to create a wholistic pandemic strategy that align's with the Quintuple Aim and supports the five aims: care-team well being, better patient care, healthier people, affordability, and health equity.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
